Atsushi Hagino
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
Journal: Clinical and experimental rheumatology
Published: December 23, 2020
Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairment.
Journal: Clinical and experimental nephrology
Published: September 18, 2019
A drug-drug interaction study of a novel, selective urate reabsorption inhibitor dotinurad and the non-steroidal anti-inflammatory drug oxaprozin in healthy adult males.
Journal: Clinical and experimental nephrology
Published: September 17, 2019
Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate.
Journal: Annals of the rheumatic diseases
Published: August 02, 2017
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study.
Journal: Intestinal research
Published: June 30, 2017
Long-term use of dienogest in the treatment of painful symptoms in adenomyosis.
Journal: The journal of obstetrics and gynaecology research
Published: January 26, 2017
Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study.
Journal: Fertility and sterility
Published: January 22, 2017
Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study.
Journal: Intestinal research
Published: October 10, 2016
Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study.
Journal: Intestinal research
Published: October 10, 2016
Long-term administration of escitalopram in patients with social anxiety disorder in Japan.
Journal: Neuropsychiatric disease and treatment
Published: August 16, 2016
A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan.
Journal: Current medical research and opinion
Published: January 26, 2016
Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: December 17, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026